Access cutting-edge esophageal cancer treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Access esophageal cancer specialists in Aurora at no cost
This study follows strict safety protocols and ethical guidelines
All study-related esophageal cancer treatment provided free
This study evaluates a novel regimen of induction chemotherapy using a combination of docetaxel, oxaliplatin, and leucovorin, with short term infusional 5-FU (FLOT), given prior to chemoradiotherapy with concurrent carboplatin and paclitaxel, as neoadjuvant therapy prior to definitive surgical resection for patients with adenocarcinoma of the esophagus or gastroesophageal junction
Sponsor: University of Colorado, Denver
Check if you qualify for this esophageal cancer clinical trial in Aurora, CO
If you're searching for esophageal cancer treatment options in Aurora, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced esophageal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.